MX2018001528A - Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. - Google Patents
Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña.Info
- Publication number
- MX2018001528A MX2018001528A MX2018001528A MX2018001528A MX2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A
- Authority
- MX
- Mexico
- Prior art keywords
- sumatripan
- treating migraine
- pharmaceutical composition
- sumatriptan
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente solicitud se relaciona a un método de tratamiento de migraña o terrible dolor de cabeza en un paciente humano, el método que comprende administrar la vcomposición subcutáneamente que comprende sumatriptán o su sal farmacéuticamente aceptable, en una cantidad equivalente a 3 mg de base de sumatriptán.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4076CH2015 | 2015-08-05 | ||
US15/011,357 US10537554B2 (en) | 2015-08-05 | 2016-01-29 | Pharmaceutical composition for treating migraine |
PCT/US2016/015961 WO2017023361A1 (en) | 2015-08-05 | 2016-02-01 | Pharmaceutical composition comprising sumatripan for treating migraine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018001528A true MX2018001528A (es) | 2018-04-24 |
Family
ID=58053922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018001528A MX2018001528A (es) | 2015-08-05 | 2016-02-01 | Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. |
Country Status (6)
Country | Link |
---|---|
US (3) | US10537554B2 (es) |
EP (1) | EP3331524A1 (es) |
CN (1) | CN107921023A (es) |
BR (1) | BR112018002433A2 (es) |
CA (1) | CA2994748C (es) |
MX (1) | MX2018001528A (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10537554B2 (en) | 2015-08-05 | 2020-01-21 | Upsher-Smith Laboratories, Llc | Pharmaceutical composition for treating migraine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79215B (es) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
US10537554B2 (en) | 2015-08-05 | 2020-01-21 | Upsher-Smith Laboratories, Llc | Pharmaceutical composition for treating migraine |
-
2016
- 2016-01-29 US US15/011,357 patent/US10537554B2/en active Active
- 2016-02-01 EP EP16706279.3A patent/EP3331524A1/en not_active Withdrawn
- 2016-02-01 CA CA2994748A patent/CA2994748C/en active Active
- 2016-02-01 MX MX2018001528A patent/MX2018001528A/es unknown
- 2016-02-01 BR BR112018002433-3A patent/BR112018002433A2/pt not_active Application Discontinuation
- 2016-02-01 CN CN201680050798.8A patent/CN107921023A/zh active Pending
-
2019
- 2019-12-18 US US16/718,414 patent/US11364224B2/en active Active
-
2022
- 2022-06-06 US US17/833,105 patent/US20220387386A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11364224B2 (en) | 2022-06-21 |
US10537554B2 (en) | 2020-01-21 |
US20200171000A1 (en) | 2020-06-04 |
BR112018002433A2 (pt) | 2018-09-18 |
CN107921023A (zh) | 2018-04-17 |
US20170035729A1 (en) | 2017-02-09 |
EP3331524A1 (en) | 2018-06-13 |
CA2994748C (en) | 2024-02-13 |
US20220387386A1 (en) | 2022-12-08 |
CA2994748A1 (en) | 2017-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
PH12017502142A1 (en) | Tetrasubstituted aklene compounds and their use | |
JOP20160092B1 (ar) | علاج البيتا ثلاسيميا باستخدام مصطبة لجائنية | |
MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
PH12016502352A1 (en) | Pharmaceutical composition | |
PH12016502353A1 (en) | Pharmaceutical composition | |
MX2021002321A (es) | Nuevos metodos. | |
MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
MX2019005160A (es) | Formulacion farmaceutica. | |
MX2022014792A (es) | Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican. | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
MX2018001528A (es) | Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. | |
MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
MX2020001217A (es) | Metodos de tratamiento de sintomas de gastroparesia usando velusetrag. | |
EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции | |
MX2016010919A (es) | 4-bencilsulfonil-2-butenonitrilo. | |
UA82584U (ru) | Способ лечения вестибулярной мигрени и коморбидного синдрома головокружения у женщин с вестибулярной дисфункцией в перименопаузальном периоде | |
MX2015014707A (es) | Proceso de obtencion y composicion farmaceutica de esomeprazol inyectable para el tratamiento de trastornos gastricos. |